6MO Evaluation of Plasma Assessed Comprehensive Genomic Profiling Before First-Line Treatment with FOLFIRI Plus Cetuximab in RAS/BRAFV600E Wild Type Metastatic Colorectal Cancer Patients in the CAPRI 2-GOIM Trial
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined